Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.32 USD | +4.73% | +25.76% | -53.63% |
05:06pm | CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study | MT |
14/05 | Earnings Flash (CASI) CASI PHARMACEUTICALS Posts Q1 Revenue $3.4M, vs. Street Est of $12M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.63% | 4.12Cr | |
+31.28% | 59TCr | |
-3.36% | 36TCr | |
+19.18% | 33TCr | |
+5.22% | 29TCr | |
+15.32% | 24TCr | |
+10.09% | 21TCr | |
-6.95% | 20TCr | |
+9.67% | 17TCr | |
-0.61% | 16TCr |
- Stock Market
- Equities
- CASI Stock
- News CASI Pharmaceuticals, Inc.
- Transcript : CASI Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 09, 2020